How can research inform the development of evidence-based rehabilitation programs?

Jun 27, 2018 ... This research study is being done to compare the effectiveness of either 15 or 30 mg once daily of upadacitinib versus adalimumab versus a placebo to control ... Sep 17, 2012 ... In a randomized double-blind study (n = 127), science faculty from research-intensive universities rated the application materials of a ... Rituximab depletes B cells and may reduce the production of autoantibodies against PLA2R or THSD7A. Therefore, the measurement of autoantibodies in participants ... May 10, 2021 ... We report the findings of a randomized, double-blind, placebo-controlled, multi-site phase 3 clinical trial (NCT03537014) to test the efficacy ... May 15, 2020 ... Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. ... double-blind study of adjuvant pembrolizumab (pembro) with V940 (mRNA-4157) or placebo for renal cell carcinoma (RCC). Based on the phase 3 KEYNOTE-564 trial ... A Phase 3, randomized, double-blind, study evaluating efficacy and safety of riliprubart versus intravenous immunoglobulin (IVIg) in participants with chronic ... Jul 17, 2023 ... A double-blind study blinds both the subjects as well as the researchers to the treatment allocation. Jun 14, 2022 ... Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy Nov 9, 2018 ... A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with ...